Results 21 to 30 of about 3,627,754 (377)
Immunosuppressive Agents [PDF]
M F Kahn, M Bedoiseau, S de Sèze
+7 more sources
Comparative the efficacy and acceptability of immunosuppressive agents for myasthenia gravis: A protocol for systematic review and network meta-analysis. [PDF]
Xu P +16 more
europepmc +2 more sources
The number of allogeneic solid organ and bone marrow transplants is increasing all over the world. To prevent transplant rejection and treat acute rejection of transplant, immunosuppressant drugs are used.
Vikas Bhagat +4 more
semanticscholar +1 more source
Actinomycosis in a Mucosal Lesion on a Created Perioral Dimple: A Case Report [PDF]
Facial dimple creation is a simple surgical procedure. Nonetheless, several complications can occur. Actinomycosis is a rare chronic granulomatous infection caused by Actinomyces species.
Ui Geon Kim +3 more
doaj +1 more source
Immunosuppressive therapy in non-infections uveitis and retinovasculitis
Purpose: to evaluate the efficacy and safety of the immunosuppressive therapy for severe forms of non-infections uveitis and retinovasculitis.Methods: 107 patients (62 males and 45 females aged 9 to 54 years) who received low dose methotrexate — 7.5-20 ...
E. A. Drozdova
doaj +3 more sources
Safety and effectiveness of mycophenolate mofetil associated with tacrolimus for liver transplantation immunosuppression: a systematic review and meta-analysis of randomized controlled trials [PDF]
A combination of immunosuppressants may improve outcomes due to the synergistic effect of their different action mechanisms. Currently, there is no consensus regarding the best immunosuppressive protocol after liver transplantation.
Francisco Tustumi +11 more
doaj +1 more source
Background Immunosuppressive agents have been widely used in the treatment of IgA nephropathy (IgAN), but the efficacy and safety remain controversial.
Zheng Zhang +3 more
doaj +1 more source
Off-label use of rituximab in dermatology: pemphigus treatment [PDF]
Since its approval in 1997 by the FDA (United States Food and Drug Administration), rituximab has been used for certain B-cell lymphomas and treatment-resistant rheumatoid arthritis.
Lislaine Bomm +4 more
doaj +1 more source
New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies [PDF]
In the literature, several adult cases with myelin oligodendrocyte glycoprotein (MOG) antibodies (Abs)-associated disorders have been reported to have seizure and acute disseminated encephalomyelitis (ADEM) as the main clinical manifestations, but the ...
Hansol Im, Taewon Kim
doaj +1 more source

